These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32298837)

  • 1. Juvenile Paget's Disease From Heterozygous Mutation of SP7 Encoding Osterix (Specificity Protein 7, Transcription Factor SP7).
    Whyte MP; Campeau PM; McAlister WH; Roodman GD; Kurihara N; Nenninger A; Duan S; Gottesman GS; Bijanki VN; Sedighi H; Veis DJ; Mumm S
    Bone; 2020 Aug; 137():115364. PubMed ID: 32298837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation.
    Saki F; Karamizadeh Z; Nasirabadi S; Mumm S; McAlister WH; Whyte MP
    J Bone Miner Res; 2013 Jun; 28(6):1501-8. PubMed ID: 23322328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK.
    Whyte MP; Tau C; McAlister WH; Zhang X; Novack DV; Preliasco V; Santini-Araujo E; Mumm S
    Bone; 2014 Nov; 68():153-61. PubMed ID: 25063546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile Paget's disease: the second reported, oldest patient is homozygous for the TNFRSF11B "Balkan" mutation (966_969delTGACinsCTT), which elevates circulating immunoreactive osteoprotegerin levels.
    Whyte MP; Singhellakis PN; Petersen MB; Davies M; Totty WG; Mumm S
    J Bone Miner Res; 2007 Jun; 22(6):938-46. PubMed ID: 17352649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel homozygous mutations in the osteoprotegerin gene TNFRSF11B in two unrelated patients with juvenile Paget's disease.
    Naot D; Choi A; Musson DS; Simsek Kiper PÖ; Utine GE; Boduroglu K; Peacock M; DiMeglio LA; Cundy T
    Bone; 2014 Nov; 68():6-10. PubMed ID: 25108083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intermediate form of juvenile Paget's disease caused by a truncating TNFRSF11B mutation.
    Janssens K; de Vernejoul MC; de Freitas F; Vanhoenacker F; Van Hul W
    Bone; 2005 Mar; 36(3):542-8. PubMed ID: 15777670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling.
    Whyte MP
    Ann N Y Acad Sci; 2006 Apr; 1068():143-64. PubMed ID: 16831914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-onset Paget's disease of bone in a Mexican family caused by a novel tandem duplication (77dup27) in TNFRSF11A that encodes RANK.
    Iwamoto SJ; Rothman MS; Duan S; Baker JC; Mumm S; Whyte MP
    Bone; 2020 Apr; 133():115224. PubMed ID: 31923705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoprotegerin deficiency and juvenile Paget's disease.
    Whyte MP; Obrecht SE; Finnegan PM; Jones JL; Podgornik MN; McAlister WH; Mumm S
    N Engl J Med; 2002 Jul; 347(3):175-84. PubMed ID: 12124406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sporadic hyperphosphatasia syndrome featuring periostitis and accelerated skeletal turnover without receptor activator of nuclear factor-kappaB, osteoprotegerin, or sequestosome-1 gene defects.
    Simsek S; Basoski NM; Bravenboer N; Zhang X; Mumm S; Whyte MP; Netelenbos JC
    J Clin Endocrinol Metab; 2007 May; 92(5):1897-901. PubMed ID: 17284635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early identification of a 12-bp tandem duplication in TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK): Clinical characterization and response to bisphosphonate therapy.
    Craven M; Vajravelu ME; Shekdar KV; Levine MA; Mumm S; Whyte MP; Mancilla EE
    Bone; 2023 May; 170():116698. PubMed ID: 36740137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytokines in bone diseases. Osteoprotegerin and juvenile Paget's disease].
    Hosogane N; Miyamoto T
    Clin Calcium; 2010 Oct; 20(10):1540-4. PubMed ID: 20890037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile Paget's disease with compound heterozygous mutations in TNFRSF11B presenting with recurrent clavicular fractures and a mild skeletal phenotype.
    Naot D; Wilson LC; Allgrove J; Adviento E; Piec I; Musson DS; Cundy T; Calder AD
    Bone; 2020 Jan; 130():115098. PubMed ID: 31655221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile Paget's Disease: Report of a successful treatment throughout the complete growth of a patient with a missense TNFRSF11B mutation.
    Prata AR; Saraiva J; Salgado M; Estanqueiro P
    Joint Bone Spine; 2021 Dec; 88(6):105243. PubMed ID: 34166796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of chaotic trabecular structure in OPG-deficient juvenile Paget's disease patients indicates a chaogenic role for OPG in nonlinear pattern formation of trabecular bone.
    Salmon P
    J Bone Miner Res; 2004 May; 19(5):695-702. PubMed ID: 15068491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease.
    Gottesman GS; Madson KL; McAlister WH; Nenninger A; Wenkert D; Mumm S; Whyte MP
    Am J Med Genet A; 2016 Apr; 170A(4):978-85. PubMed ID: 26762549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of RANK-ligand antibody (denosumab) treatment on bone turnover markers in a girl with juvenile Paget's disease.
    Grasemann C; Schündeln MM; Hövel M; Schweiger B; Bergmann C; Herrmann R; Wieczorek D; Zabel B; Wieland R; Hauffa BP
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3121-6. PubMed ID: 23788687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of aspartate 182 in OPG causes juvenile Paget's disease by impairing both protein secretion and binding to RANKL.
    Middleton-Hardie C; Zhu Q; Cundy H; Lin JM; Callon K; Tong PC; Xu J; Grey A; Cornish J; Naot D
    J Bone Miner Res; 2006 Mar; 21(3):438-45. PubMed ID: 16491292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile Paget disease.
    Polyzos SA; Cundy T; Mantzoros CS
    Metabolism; 2018 Mar; 80():15-26. PubMed ID: 29080812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Functional Osteoprotegerin: More Than a Skeletal Problem.
    Grasemann C; Unger N; Hövel M; Arweiler-Harbeck D; Herrmann R; Schündeln MM; Müller O; Schweiger B; Lausch E; Meissner T; Kiewert C; Hauffa BP; Shaw NJ
    J Clin Endocrinol Metab; 2017 Jan; 102(1):210-219. PubMed ID: 27809640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.